Global Market Watch:
Global Cardiac Resynchronization Therapy (CRT) sector is projected to reach US$3.1 billion by 2016. The North America accounts for nearly 39% (2015) of the global value while Europe claims approximately 32% (2018). Asia-Pacific is the fastest growing region with a CAGR of 12.8% driving a market value of US$590 million by 2016. On a global scale, projections for Cardiac Resynchronization Therapy Defibrillator (CRT-D) market value indicate US$1.6 billion by 2016 leaving the rest of the market to the Cardiac Resynchronization Pacemakers (CRT-P).
Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.
The report ‘Cardiac Resynchronization Therapy (CRT) Devices - Global Trends, Estimates and Forecasts, 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on:
- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies
The analysis primarily deals with by type. Further, the subdivided categories include:
Cardiac Resynchronization Therapy (CRT) Devices – By Type
a. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
b. Cardiac Resynchronization Pacemakers (CRT-P)
The period considered for the cardiac resynchronization therapy (CRT) devices market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.
More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 130 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.